Correction to: The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons (Molecular Neurodegeneration, (2024), 19, 1, (88), 10.1186/s13024-024-00779-9)

3Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The authors wish to note the Grant ID, MFFF – 007905 relating to the mentioned grants to ZGO and EAF from the Michael J. Fox Foundation which was mistakenly omitted from the original article [1]. The authors also wish to note that Lior Greenbaum is only affiliated to affiliation #14 (Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel).

Cite

CITATION STYLE

APA

Jones-Tabah, J., He, K., Karpilovsky, N., Senkevich, K., Deyab, G., Pietrantonio, I., … Fon, E. A. (2024, December 1). Correction to: The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons (Molecular Neurodegeneration, (2024), 19, 1, (88), 10.1186/s13024-024-00779-9). Molecular Neurodegeneration . BioMed Central Ltd. https://doi.org/10.1186/s13024-024-00791-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free